Fermenta Biotech Limited develops enzymatic synthesis of Molnupiravir - an investigational COVID-19 therapeutic drug

Novel technology using green chemistry is sustainable, efficient and scalable. The experimental antiviral drug Molnupiravir was developed at Emory University in Atlanta by Drug Innovation Ventures at Emory (DRIVE).
Fermenta Biotech Limited develops enzymatic synthesis of Molnupiravir - an investigational COVID-19 therapeutic drug
Representative Image

New Delhi

Related Stories

No stories found.